Showing 1 - 16 results of 16 for search 'Suresh Senan', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Accuracy of deformable image registration-based intra-fraction motion management in Magnetic Resonance-guided radiotherapy by Miguel A. Palacios, Georgi Gerganov, Paul Cobussen, Shyama U. Tetar, Tobias Finazzi, Berend J. Slotman, Suresh Senan, Cornelis J.A. Haasbeek, Iwan Kawrakow
Published 2023-04-01
Article -
5
-
6
-
7
Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review by Lukas Käsmann, Alexander Dietrich, Claudia A. Staab-Weijnitz, Farkhad Manapov, Jürgen Behr, Andreas Rimner, Branislav Jeremic, Suresh Senan, Dirk De Ruysscher, Kirsten Lauber, Claus Belka
Published 2020-09-01
Article -
8
X-change symposium: status and future of modern radiation oncology—from technology to biology by Stefanie Corradini, Maximilian Niyazi, Dirk Verellen, Vincenzo Valentini, Seán Walsh, Anca-L. Grosu, Kirsten Lauber, Amato Giaccia, Kristian Unger, Jürgen Debus, Bradley R. Pieters, Matthias Guckenberger, Suresh Senan, Wilfried Budach, Roland Rad, Julia Mayerle, Claus Belka
Published 2021-02-01
Article -
9
Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases by Gamze Ugurluer, Famke L. Schneiders, Stefanie Corradini, Luca Boldrini, Rupesh Kotecha, Patrick Kelly, Lorraine Portelance, Philip Camilleri, Merav A. Ben-David, Spencer Poiset, Sebastian N. Marschner, Giulia Panza, Tugce Kutuk, Miguel A. Palacios, Alessandra Castelluccia, Teuta Zoto Mustafayev, Banu Atalar, Suresh Senan, Enis Ozyar
Published 2024-05-01
Article -
10
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer u... by Tanja D de Gruijl, Teodora Radonic, Marc C Huisman, Idris Bahce, Johanna E E Pouw, Sayed M S Hashemi, Jessica E Wijngaarden, Maarten Slebe, Daniela E Oprea-Lager, Gerben J C Zwezerijnen, Danielle Vugts, Ezgi B Ulas, Suresh Senan, C Willemien Menke-van der Houven van Oordt
Published 2024-02-01
Article -
11
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial by Chris Dickhoff, Suresh Senan, Famke L. Schneiders, Joris Veltman, Sayed Hashemi, Johannes M. A. Daniels, Marieke Fransen, David J. Heineman, Teodora Radonic, Peter M. van de Ven, Imke H. Bartelink, Lilian J. Meijboom, Juan J. Garcia-Vallejo, Daniela E. Oprea-Lager, Tanja D. de Gruijl, Idris Bahce
Published 2020-08-01
Article -
12
Superior Sulcus Tumors Invading the Spine: Multimodal Treatment Outcomes From the Preimmunotherapy Era by Semih Unal, BS, Ricardo Feller, MD, Agnita Stadhouder, MD, David.J. Heineman, MD, PhD, Timothy U. Jiya, MD, Martijn van Dorp, MD, Idris Bahce, MD, PhD, Jerry Braun, MD, PhD, Suresh Senan, MD, PhD, Max Dahele, MBChB., PhD, Chris Dickhoff, MD, PhD
Published 2023-12-01
Article -
13
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study by Tanja D de Gruijl, Lilian J Meijboom, Teodora Radonic, Chris Dickhoff, Idris Bahce, Sayed M S Hashemi, Daniela E Oprea-Lager, Ezgi B Ulas, Suresh Senan, Famke L Schneiders, Joris Veltman, David J Heineman, Anne Vrijmoet, Ilias Houda, Joyce Bakker, Peter van de Ven, Natalja Bouwhuis, Febe van Maldegem, Marieke F Fransen
Published 2024-09-01
Article -
14
Salvage Surgery for Patients With Local Recurrence or Persistent Disease After Treatment With Chemoradiotherapy for SCLC by Pieter J.M. Joosten, MD, Toon A. Winkelman, MD, David J. Heineman, MD, PhD, Sayed M.S. Hashemi, MD, Idris Bahce, MD, PhD, Suresh Senan, MD, PhD, Marinus A. Paul, MD, PhD, Koen J. Hartemink, MD, PhD, Max Dahele, MbChB., PhD, Chris Dickhoff, MD, PhD
Published 2021-05-01
Article -
15
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial by David A. Palma, Robert Olson, Stephen Harrow, Rohann J. M. Correa, Famke Schneiders, Cornelis J. A. Haasbeek, George B. Rodrigues, Michael Lock, Brian P. Yaremko, Glenn S. Bauman, Belal Ahmad, Devin Schellenberg, Mitchell Liu, Stewart Gaede, Joanna Laba, Liam Mulroy, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Andrew Warner, Ben J. Slotman, Tanja D. de Gruijl, Alison Allan, Suresh Senan
Published 2019-08-01
Article -
16
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis by Merle I. Ronden, MD, Idris Bahce, MD, PhD, Niels J.M. Claessens, MD, Nicole Barlo, MD, Max R. Dahele, MD, PhD, Johannes M.A. Daniels, MD, PhD, Caroline Tissing-Tan, MD, Edo Hekma, MD, Sayed M.S. Hashemi, MD, Antoinet van der Wel, MD, Femke O.B. Spoelstra, MD, PhD, Wilko F.A. R. Verbakel, MD, PhD, Marian A. Tiemessen, MD, Marjolein van Laren, MD, Annemarie Becker, MD, PhD, Svitlana Tarasevych, MD, Cornelis J.A. Haasbeek, MD, PhD, Karen Maassen van den Brink, MD, Chris Dickhoff, MD, PhD, Suresh Senan, MRCP, FRCR, PhD
Published 2021-07-01
Article